Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-Dose Pilocarpine for Prevention of Radiation-Induced Xerostomia in Head and Neck Cancer Patients
TCTR20250618006Phase 3Not yet recruiting
- Sponsor
- Department of Otolaryngology
- Start
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pilocarpine in head and neck cancer (HNC), radiation-induced hyposalivation (RIX), sponsored by Department of Otolaryngology. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
pilocarpine
03
Conditions
head and neck cancer (HNC)radiation-induced hyposalivation (RIX)
Beyond the preview
Go deeper on TCTR20250618006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250618006.